McBride, Jacqueline

Cryopyrin activates the inflammasome in response to toxins and ATP

Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., & Dixit, V. M. (2006) · Nature

Inflammasome and immune disordersImmune Response and Inflammation

Cited by 3,080

Preclinical pharmacokinetics, pharmacodynamics, tissue distribution, and tumor penetration of anti-PD-L1 monoclonal antibody, an immune checkpoint inhibitor

Deng, R., Bumbaca, D., Pastuskovas, C. V., Boswell, C. A., West, D., Cowan, K. J., Chiu, H., McBride, J., Johnson, C., Xin, Y., et al. (2016) · mAbs

Cancer Immunotherapy and BiomarkersMonoclonal and Polyclonal Antibodies Research

Cited by 199

First‐in‐human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC‐2394, in healthy volunteers

Tang, F., Kunder, R., Chu, T., Hains, A., Nguyen, A., McBride, J. M., Zhong, Y., Santagostino, S., Wilson, M., Trenchak, A., et al. (2023) · Clinical and Translational Science

Inflammasome and immune disordersPharmacogenetics and Drug Metabolism

Cited by 70

P0928 Patient endotypes in ulcerative colitis revealed by longitudinal symptom trajectories under therapy

El Houjjaji, C., Paun, A., McBride, J., Schreiber, S., & Mueller-Breckenridge, A. J. (2025) · Journal of Crohn's and Colitis

Inflammatory Bowel DiseaseOcular Diseases and Behçet’s Syndrome

Cited by 2